Benjamin M Ellingson
Overview
Explore the profile of Benjamin M Ellingson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
265
Citations
7120
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanvito F, Yao J, Cho N, Telesca D, Salamon N, Cloughesy T, et al.
Neuroradiology
. 2025 Mar;
PMID: 40067460
The universalizability of the metric percentage of signal recovery (PSR) derived from dynamic susceptibility contrast (DSC) perfusion MRI is limited by its dependency of acquisition parameters. In this technical assessment,...
2.
Ellingson B, Okobi Q, Chong R, Plawat R, Zhao E, Gafita A, et al.
Neurooncol Adv
. 2025 Mar;
7(1):vdaf022.
PMID: 40051661
Background: To demonstrate the potential value of F-fluorodeoxyglucose positron emission tomography (F-FDG PET) as a rapid, non-invasive metabolic imaging surrogate for pharmacological modulation of EGFR signaling in EGFR-driven GBM, we...
3.
Venneti S, Kawakibi A, Ji S, Waszak S, Sweha S, Mota M, et al.
Cancer Discov
. 2025 Mar;
15(3):657.
PMID: 40025951
No abstract available.
4.
Lopez Kolkovsky A, Wang C, Yao J, Ellingson B
NMR Biomed
. 2025 Feb;
38(3):e70003.
PMID: 39948226
MRI in vivo is a powerful clinical diagnosis tool as it allows acquiring noninvasively images with an ample range of contrasts. Advanced imaging techniques such as chemical exchange saturation transfer...
5.
Raymond C, Yao J, Clifford B, Feiweier T, Oshima S, Telesca D, et al.
AJNR Am J Neuroradiol
. 2025 Feb;
PMID: 39947682
Backgound And Purpose: This study utilizes a physics-based approach to synthesize realistic MR artifacts and train a deep learning generative adversarial network (GAN) for use in artifact reduction on EPI,...
6.
Riviere-Cazaux C, Keough M, Zuccato J, Kumar R, Schulz S, Warrington A, et al.
Neuro Oncol
. 2025 Jan;
PMID: 39786477
Cerebrospinal fluid (CSF) has emerged as a valuable liquid biopsy source for glioma biomarker discovery and validation. CSF produced within the ventricles circulates through the subarachnoid space, where the composition...
7.
Ellingson B, Sanvito F, Pope W, Cloughesy T, Huang R, Villanueva-Meyer J, et al.
AJNR Am J Neuroradiol
. 2024 Dec;
46(1):221-222.
PMID: 39730160
No abstract available.
8.
Oshima S, Kim A, Sun X, Rifi Z, Cross K, Fu K, et al.
AJNR Am J Neuroradiol
. 2024 Dec;
46(2):330-340.
PMID: 39730158
Background And Purpose: Precise and individualized targeting of the ventral intermediate thalamic nucleus for the MR-guided focused ultrasound is crucial for enhancing treatment efficacy and avoiding undesirable side effects. In...
9.
de la Fuente M, Touat M, van den Bent M, Preusser M, Peters K, Young R, et al.
Neuro Oncol
. 2024 Dec;
PMID: 39723472
Isocitrate dehydrogenase (IDH)-mutant gliomas are the most common malignant primary brain tumors in young adults. This condition imposes a substantial burden on patients and their caregivers, marked by neurocognitive deficits...
10.
Oshima S, Yao J, Bobholz S, Nagaraj R, Raymond C, Teraishi A, et al.
CNS Oncol
. 2024 Nov;
13(1):2415285.
PMID: 39535237
A radio-pathomic machine learning (ML) model has been developed to estimate tumor cell density, cytoplasm density (Cyt) and extracellular fluid density (ECF) from multimodal MR images and autopsy pathology. In...